Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits - PubMed (original) (raw)
Therapeutic window for nonerythropoietic carbamylated-erythropoietin to improve motor function following multiple infarct ischemic strokes in New Zealand white rabbits
Paul A Lapchak et al. Brain Res. 2008.
Abstract
Carbamylated erythropoietin (CEPO) is a novel neuroprotective agent that does not bind to the classical erythropoietin receptor or affect hematocrit. Since CEPO has not been systematically studied in a fully blinded and randomized manner in an embolic stroke model, we determined if CEPO would be useful to attenuate clinical deficits associated with multiple infarct ischemia using the rabbit small clot embolic stroke model (RSCEM). Rabbits were embolized and treated with vehicle or CEPO within 6 h of embolization and behavioral analysis was conducted 48 h after embolization. Using quantal analysis, we determined the quantity of blood clot (mg) in brain that produce neurologic dysfunction in 50% of the rabbits (P(50)), with intervention considered beneficial if it increased the P(50) compared to controls. CEPO administered between 5 min and 3 h after embolization significantly (p<0.05) improved behavioral function and increased the P(50) value by 55-216%. However, CEPO administration did not improve behavior when administered 6 h following embolization. In conclusion, in the RSCEM, CEPO had a therapeutic window of at least 3 h, where it effectively improved clinical rating scores and motor function. Our results suggest that CEPO may be useful to treat acute ischemic stroke and supports the study of CEPO in stroke patients.
Similar articles
- Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.
Villa P, van Beek J, Larsen AK, Gerwien J, Christensen S, Cerami A, Brines M, Leist M, Ghezzi P, Torup L. Villa P, et al. J Cereb Blood Flow Metab. 2007 Mar;27(3):552-63. doi: 10.1038/sj.jcbfm.9600370. Epub 2006 Jul 12. J Cereb Blood Flow Metab. 2007. PMID: 16835629 - Carbamylated erythropoietin to treat neuronal injury: new development strategies.
Lapchak PA. Lapchak PA. Expert Opin Investig Drugs. 2008 Aug;17(8):1175-86. doi: 10.1517/13543784.17.8.1175. Expert Opin Investig Drugs. 2008. PMID: 18616414 Review. - Recanalization and reperfusion therapies for acute ischemic stroke.
Molina CA, Alvarez-Sabín J. Molina CA, et al. Cerebrovasc Dis. 2009;27 Suppl 1:162-7. doi: 10.1159/000200455. Epub 2009 Apr 3. Cerebrovasc Dis. 2009. PMID: 19342847 Review.
Cited by
- Effect of carbamylated erythropoietin on neuronal apoptosis in fetal rats during intrauterine hypoxic-ischemic encephalopathy.
Diao M, Qu Y, Liu H, Ma Y, Lin X. Diao M, et al. Biol Res. 2019 May 13;52(1):28. doi: 10.1186/s40659-019-0234-7. Biol Res. 2019. PMID: 31084604 Free PMC article. - Data Standardization and Quality Management.
Lapchak PA, Zhang JH. Lapchak PA, et al. Transl Stroke Res. 2018 Feb;9(1):4-8. doi: 10.1007/s12975-017-0531-9. Epub 2017 Mar 10. Transl Stroke Res. 2018. PMID: 28283966 - Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling.
Adav SS, Sze SK. Adav SS, et al. Mol Brain. 2016 Nov 3;9(1):92. doi: 10.1186/s13041-016-0272-9. Mol Brain. 2016. PMID: 27809929 Free PMC article. Review. - Neuroprotection and CD131/GDNF/AKT Pathway of Carbamylated Erythropoietin in Hypoxic Neurons.
Ding J, Wang J, Li QY, Yu JZ, Ma CG, Wang X, Lu CZ, Xiao BG. Ding J, et al. Mol Neurobiol. 2017 Sep;54(7):5051-5060. doi: 10.1007/s12035-016-0022-0. Epub 2016 Aug 19. Mol Neurobiol. 2017. PMID: 27541284 - Revisiting the role of erythropoietin for treatment of ocular disorders.
Shirley Ding SL, Leow SN, Munisvaradass R, Koh EH, Bastion ML, Then KY, Kumar S, Mok PL. Shirley Ding SL, et al. Eye (Lond). 2016 Oct;30(10):1293-1309. doi: 10.1038/eye.2016.94. Epub 2016 Jun 10. Eye (Lond). 2016. PMID: 27285322 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials